What: Hormone therapy has dropped significantly since 2007 across all age groups of potentially menopausal women, according to research presented at the Menopause Society’s annual meeting in Chicago. Researchers looked at insurance claims data from millions of women and found hormone therapy went from around 5 percent in 2007 to just under 2 percent in 2023.
Why it matters: Despite research that has shown hormone therapy can safely treat hot flashes and night sweats in women with proper risk analysis, usage has not recovered in recent years. As Stephanie Faubion, medical director of The Menopause Society, put it: “These findings suggest that substantial barriers to HT use remain, and additional efforts are needed to educate women and clinicians about menopause management and HT use more specifically.”
Source: Medical Xpress // Menopause Society